Allele-Specific Primer Mismatch for BRAF SNP Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting BRAF mutations, such as sequencing and real-time PCR, face limitations in sensitivity and specificity, particularly in differentiating between specific mutations like V600E and V600K, and require complex assay workflows and extensive sample handling, which can lead to non-specific amplification and contamination issues.
Innovation Solution
A method involving peptide nucleic acid (PNA) clamps and allele-specific primers with additional mismatched bases is introduced, allowing for efficient amplification of targeted mutations while suppressing non-specific targets, enabling sensitive and specific detection of SNPs in the BRAF gene, including V600E and V600K, with improved assay efficiency and reduced contamination.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If allele specific PCR is used to detect SNPs, then specificity is improved, but sensitivity deteriorates when mutant content is very low
Solution Approach 1:
The patent introduces a mismatched base (e.g., inosine or a specific nucleotide mismatch) at the 3' end of the allele-specific primer as an intermediary element. This mismatched base acts as a mediator that reduces the affinity of the primer for the wild-type template more than for the mutant template, thereby enhancing the differential amplification efficiency. This resolves the contradiction by improving specificity through selective suppression of wild-type amplification while maintaining sensitivity for low-level mutant detection.
Solution Approach 2:
The patent modifies the chemical parameters of the primer by introducing a mismatched base at the 3' end, which changes the binding thermodynamics. This parameter change creates a larger difference in melting temperature and binding affinity between wild-type and mutant primer-template hybrids. The result is improved specificity for mutant detection while maintaining the ability to detect low mutant content through enhanced differential amplification efficiency.
2Productivity
If standard PCR amplification is used, then amplification efficiency is improved, but non-specific amplification increases
Solution Approach 1:
The patent converts the potential harm of non-specific amplification into a benefit by deliberately designing the allele-specific primer with a mismatched base at the 3' end. This mismatched base ensures that the primer binds poorly to the wild-type template (reducing non-specific amplification) while maintaining sufficient binding to the mutant template (preserving specific amplification). The mismatched base transforms what would normally be a source of error into a selective advantage for specific mutant detection.
3Measurement precision
If complex assay workflows are used to improve detection accuracy, then measurement precision is improved, but device complexity increases
Solution Approach 1:
The patent extracts the critical differentiation function from complex post-PCR analysis workflows and embeds it directly into the primer design itself. By incorporating the mismatched base at the 3' end of the allele-specific primer, the assay inherently differentiates between wild-type and mutant templates during the amplification process itself. This eliminates the need for complex downstream analysis steps, reducing assay workflow complexity while maintaining high detection accuracy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach achieves sensitive detection of BRAF mutations at levels as low as 0.5% mutant content with high specificity, effectively differentiating between specific mutations and reducing non-specific amplification, thus enhancing the accuracy and efficiency of cancer diagnosis and prognosis.
Implementation Method 1
at least one peptide nucleic acid (PNA) clamp, wherein the at least one PNA clamp blocks the amplification from wild-type target
Implementation Method 2
the last three nucleotides at the 3' terminus of the primer encodes X and wherein the fourth nucleotide from the 3' terminus contains a mismatched base, wherein, if X is present, the primer anneals to X
Implementation Method 3
amplification reaction produces an amplification product comprising X
Data Source
Figure 1
Figure 2
Figure 2
AI summary
A method of designing a primer for detecting a single nucleotide polymorphism (SNP), a method of detecting an SNP, a method of distinguishing SNPs, primers, detectable oligonucleotides, and kits.